-+ 0.00%
-+ 0.00%
-+ 0.00%

AI DRUG DISCOVERY PIONEER, NANYANG BIOLOGICS PTE. LTD., ENTERS INTO BUSINESS COMBINATION AGREEMENT WITH RF ACQUISITION CORP II IN US$1.5B TRANSACTION TO PURSUE PUBLIC LISTING

Reuters·10/02/2025 11:50:35

Please log in to view news